Hanik KholidahThe landscape of neurodegenerative research is increasingly focusing on the profound disparities between how men and women experience cognitive decline. With over 7 million Americans currently diagnosed with Alzheimer’s disease,…
Hanik KholidahThe medical community has long sought a non-invasive, cost-effective, and highly accurate method for diagnosing Alzheimer’s disease in its earliest stages. In recent years, the development of blood-based biomarkers has…
Hanik KholidahThe scientific community has long viewed the progression of Alzheimer’s disease as an irreversible trajectory of cognitive decay and neuronal loss. However, a landmark study published in the journal Cell…
Hanik KholidahThe landscape of neurodegenerative research is undergoing a significant shift as new evidence suggests that dopamine, a neurotransmitter long associated primarily with reward and motor control, may play a much…
Hanik KholidahLithium has occupied a unique and often controversial space in the pharmacopeia for nearly a century. Long established as the "gold standard" for the treatment of bipolar disorder, the mineral…
Hanik KholidahThe routine fasting blood sugar test administered during annual physical examinations may be failing to capture a critical indicator of long-term cognitive decline. While millions of patients receive a clean…
